Percutaneous Ablation of VX2 Carcinoma-induced Liver Tumors with Use of Ethanol versus Acetic Acid: Pilot Study in a Rabbit Model

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 1 I, 2004, Pages 63-67

  Shah, Samir S ^a   Jacobs, Darick L ^b   Krasinkas, Alyssa M ^a   Furth, Emma E ^a   Itkin, Maxim ^a   Clark, Timothy W I ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; COAGULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; DRUG DIFFUSION; HISTOPATHOLOGY; INFUSION; LAPAROTOMY; LIVER; LIVER CELL CARCINOMA; LIVER PARENCHYMA; NONHUMAN; PERCUTANEOUS ABLATION; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

EID: 1642576997     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000106388.63463.9A     Document Type: Article

References (25)

1. Ohnishi K, Ohyama N, Ito S, Fujiwara K. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 1994; 193:747-752.
2. Jacobs DL, Clark TWI, Soulen MC. Parenchymal diffusion following hepatic injection of acetic acid versus ethanol (abstr). J Vasc Interv Radiol 2001; 12(suppl):S23.
3. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996; 24:1379-85.
4. Fan ST. Can small hepatocellular carcinoma be cured by percutaneous acetic acid injection? HPB Surg 1997; 10:340-341.
5. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27:67-72.
6. Girard MS, Kono Y, Sirlin CB, et al. B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors. Acad Radiol 2001; 8:734-740.
7. Boehm T, Malich A, Goldberg SN, et al. Radio-frequency ablation of VX2 rabbit tumors: assessment of completeness of treatment by using contrast-enhanced harmonic power Doppler US. Radiology 2002; 225:815-821.
8. Hauff P, Fitzsch T, Reinhardt M, et al. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997; 32:94-99.
9. Boehm T, Malich A, Reichenbach JR, Fleck M, Kaiser WA. Percutaneous radio-frequency (RF) thermal ablation of rabbit tumors embedded in fat: a model for RF ablation of breast tumors. Invest Radiol 2001; 36:480-486.
10. Geschwind JFH, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000; 11:1245-1255.
11. Parkin DM, Whelan SL, Ferlay J, et al, eds. Cancer incidence in five continents, volume VII. Lyon, France: IARC Scientific Publications, 1997.
12. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36:S74-83.
13. Livraghi T, Bolondi L, Buscarini L, et al, for the Italian Cooperative HCC Study Group. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995; 22:522-526.
14. Ebara M, Nibei T, Ohto M. Intratumoral injection of absolute ethanol for treatment of small hepatocellular carcinoma. Naika 1988; 61:665-669.
15. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
16. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32:269-278.
17. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 1991; 68:1524-1530.
18. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: a multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32:1168-1173.
19. Koda M, Tanaka H, Murawaki Y, et al. Liver perforation: a serious complication of percutaneous acetic acid injection for hepatocellular carcinoma. Hepatogastroenterology 2000; 47:1110-1112.
20. Van Hoof M, Joris JP, Horsmans Y, Geubel A. Acute renal failure requiring hemodialysis after high doses percutaneous acetic acid injection for hepatocellular carcinoma. Acta Gastroenterol Belg 1999; 62:49-51.
21. Ohnishi K, Nomura F, Ito S, Fujiwara K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology 1996; 23:994-1002.
22. Ohnishi K. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatogastroenterology 1998; 45(suppl 3):1254-1258.
23. Dimitrakopoulou-Strauss, A, Straus LG, Gutzler F, et al. Pharmokinetic imaging of 11C ethanol with positron emission tomography in eight patients with hepatocellular carcinomas who were scheduled for treatment with percutaneous ethanol injection. Radiology 1999; 211:681-686.
24. Arrive L, Rosmorduc O, Dahan H. Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. AJR Am J Roentgenol 2003; 180:159-162.
25. Roberts DA, Rosen M, Clark TWI, et al. Real-time chemical shift MRI of acetic acid during percutaneous chemical ablation therapy. J Vasc Interv Radiol 2002; 13:1055-1059.